Fri, September 22, 2023

Brian Abrahams Reiterated (XENE) at Buy and Held Target at $51 on, Sep 22nd, 2023

Brian Abrahams of RBC Capital, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $51 on, Sep 22nd, 2023.

Brian has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $58 on, Tuesday, August 22nd, 2023
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $47 on, Thursday, August 10th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 10th, 2023
  • Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $49 on, Thursday, June 15th, 2023